Human growth hormone (hGH) is a peptide hormone that is synthesized and secreted by the somatotropic cells of the anterior pituitary gland. Somatropin injection is used to replace growth hormone (a natural hormone produced by your body) in adults and children with growth hormone deficiency.

Granulocyte colony-stimulating factor (G-CSF or GCSF), also known as colony-stimulating factor 3 (CSF 3), is a glycoprotein that stimulates the bone marrow to produce granulocytes and stem cells and release them into the bloodstream.

This Tocilizumab (Actemra®) ELISA kit allows researchers to measure anti-tocilizumab antibodies in biological matrices. This immunogenicity assay employs the bridging ELISA technique. Capture antibody (Tocilizumab) is pre-coated onto a 96 well microplate.

Pembrolizumab ELISA Keytruda ELISA Biosimilars. The Pembrolizumab ELISA kit is designed to measure free Pembrolizumab with high specificity and sensitivity.

This immunogenicity assay measures the presence of mouse IgM in serum or plasma that bind to immobilized PEG using the direct ELISA technique.

This immunogenicity assay measures the presence of mouse IgG in serum or plasma that bind to immobilized PEG using the direct ELISA technique.

This immunogenicity assay measures the presence of human IgM in serum or plasma that bind to immobilized PEG using the direct ELISA technique.

This immunogenicity assay measures the presence of human IgG in serum or plasma that bind to immobilized PEG using the direct ELISA technique.

Rituximab ELISA Rituxan ELISA immunogenicity Biosimilars

This Trastuzumab (Herceptin®) Immunogenicity ELISA kit allows researchers to qualitatively monitor the presence of anti-Trastuzumab antibodies in biological matrices. Trastuzumab (Herceptin® ) is a humanized recombinant monoclonal antibody used for the treatment of primary breast cancers overexpressing human epidermal growth factor 2 (HER2).

The Tocilizumab ELISA kit is designed to measure free Tocilizumab with high specificity and sensitivity. Tocilizumab (Actemra®) is an immunosuppressive humanized monoclonal antibody drug, mainly for the treatment of rheumatoid arthritis (RA) and systemic juvenile idiopathic arthritis, a severe form of arthritis in children.

Natalizumab (Tysabri®) is a humanized monoclonal antibody against the cell adhesion molecule α4-integrin used in treatment of multiple sclerosis and Crohn’s disease.

This Adalimumab (Humira®) ELISA kit is designed to measure free Adalimumab with high specificity and sensitivity, through use of a pair of antibodies.

The Infliximab ELISA kit can be used for monitoring infliximab during clinical research and offers scientists a tool for understanding the safety and efficacy of the Infliximab and its biosimilars.

The Omalizumab PK ELISA kit is designed to measure Omalizumab in serum or plasma with high specificity and sensitivity through sandwich technique.

This Trastuzumab (Herceptin) ELISA Pharmacokinetic kit is designed to measure trastuzumab with high specificity and enhanced sensitivity.

This Rituximab (Rituxan®) ELISA kit is designed to measure Rituximab with high specificity and enhanced sensitivity. Rituximab is a chimeric monoclonal antibody used in the treatment of diseases characterized by abnormal or excessive B cells.

Etanercept (Enbrel®) is a protein drug used to treat autoimmune diseases by adsorbing tumor necrosis factor (TNF; a soluble inflammatory cytokine).

This Cetuximab (Erbitux®) kit includes a chimeric IgG1 monoclonal antibody that binds the extra-cellular domain of the epidermal growth factor receptor.

The Bevacizumab ELISA kit is designed to measure free Bevacizumab with high specificity and sensitivity, through use of a pair of antibodies.